The anti-TNFs have been overlooked as a potential treatment for the hyper-inflammatory complications of severe COVID-19 lung disease, says rheumatologists. There is biological plausibility and also data from observational studies to support the use of anti-TNFs in treating the cytokine drivers of adult respiratory distress syndrome (ARDS) in COVID-19 disease, according to Professor Philip Robinson ...
Imperative to trial anti-TNFs in COVID-19: rheumatologists
By Michael Woodhead
7 Sep 2020